-
1-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]-4-(methylsulfanyl)butanamido}acetamido)-3-phenylpropanoyl]pyrrolidine-2-carboxamide
-
ChemBase ID:
103786
-
Molecular Formular:
C30H40N6O6S
-
Molecular Mass:
612.7402
-
Monoisotopic Mass:
612.27300403
-
SMILES and InChIs
SMILES:
CSCCC(NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)N
Canonical SMILES:
CSCCC(C(=O)NCC(=O)NC(C(=O)N1CCCC1C(=O)N)Cc1ccccc1)NC(=O)C(Cc1ccc(cc1)O)N
InChI:
InChI=1S/C30H40N6O6S/c1-43-15-13-23(35-28(40)22(31)16-20-9-11-21(37)12-10-20)29(41)33-18-26(38)34-24(17-19-6-3-2-4-7-19)30(42)36-14-5-8-25(36)27(32)39/h2-4,6-7,9-12,22-25,37H,5,8,13-18,31H2,1H3,(H2,32,39)(H,33,41)(H,34,38)(H,35,40)
InChIKey:
UIRWGVLTPPSGEN-UHFFFAOYSA-N
-
Cite this record
CBID:103786 http://www.chembase.cn/molecule-103786.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
1-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]-4-(methylsulfanyl)butanamido}acetamido)-3-phenylpropanoyl]pyrrolidine-2-carboxamide
|
|
|
IUPAC Traditional name
|
1-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]-4-(methylsulfanyl)butanamido}acetamido)-3-phenylpropanoyl]pyrrolidine-2-carboxamide
|
|
|
Synonyms
|
Tyr-D-Met-Gly-Phe-Pro-NH2
|
[D-Met2, Pro5]-ENKEPHALINAMIDE
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
9.509703
|
H Acceptors
|
7
|
H Donor
|
6
|
LogD (pH = 5.5)
|
-2.3395708
|
LogD (pH = 7.4)
|
-0.6687679
|
Log P
|
-0.30755717
|
Molar Refractivity
|
163.0119 cm3
|
Polarizability
|
63.629078 Å3
|
Polar Surface Area
|
196.95 Å2
|
Rotatable Bonds
|
15
|
Lipinski's Rule of Five
|
false
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
MP Biomedicals
MP Biomedicals -
02152834
|
A highly active analog of [Met5]-enkephalin which is more resistant to proteolytic degradation. This product has a molar potency ratio of 5.5 relative to morphine. |
PATENTS
PATENTS
PubChem Patent
Google Patent